Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate)

Efavirenz (EFV) is a non-nucleoside reverse transcriptase inhibitor used in first-line combination antiretroviral therapy (cART). It is usually administered with nucleoside reverse transcriptase inhibitors (NRTI), many of which are substrates of OCT uptake solute carriers (SLC22A) and MATE (SLC47A),...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceckova, Martina, Reznicek, Josef, Deutsch, Birgit, Fromm, Martin F., Staud, Frantisek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095608/
https://www.ncbi.nlm.nih.gov/pubmed/30114293
http://dx.doi.org/10.1371/journal.pone.0202706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095608/
https://www.ncbi.nlm.nih.gov/pubmed/30114293
http://dx.doi.org/10.1371/journal.pone.0202706

Ejemplares similares